Positive Results For Neuropathy Treatment Announced By Leading Medical Company
Breaking News: Positive Results for Govorestat (AT-007) in INSPIRE Phase 3 Trial, a Major Step Forward in the Treatment of SORD Deficiency.
Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.
In a significant medical breakthrough, Applied Therapeutics has announced positive results from the 12-month interim analysis of Govorestat (AT-007) in the ongoing INSPIRE Phase 3 Trial. The trial targets Sorb…